It's too early to make such assumptions. There are a few...

It's too early to make such assumptions.
There are a few elements that need to go right for Appen to benefit.
- Cost of capital is high and hampering growth - Russell 2000 isn't making new highs despite AI - lots of small companies like Innodata have pivoted to AI data in Rus 2k and they are going well.

- Appen needs a more favourable pcp when reporting. Big tech; namely Rater Labs has been in decline since 2000 - it was a part of the Leapforce acquisition it did well early doors but management failed to act and sell Rater labs. This was a drag when reporting growth not the business where it continues to grow through China and Model Builders unfortunately Rater Labs was a big part of the business and concentrated towards Big tech. That drag is now gone. But could have done better managing it and selling it.